Literature DB >> 29780858

Can visuospatial measures improve the diagnosis of Alzheimer's disease?

Shirin Salimi1, Muireann Irish2,3, David Foxe2, John R Hodges4,3, Olivier Piguet2,3, James R Burrell4,3,5.   

Abstract

INTRODUCTION: Overlapping and evolving symptoms lead to ambiguity in the diagnosis of dementia. Visuospatial function relies on parietal lobe function, which may be affected in the early stages of Alzheimer's disease (AD). This review evaluates visuospatial dysfunction in patients with AD, frontotemporal dementia, dementia with Lewy bodies, and vascular dementia to determine the diagnostic and prognostic potential of visuospatial tasks in AD.
METHODS: A systematic search of studies (1960-2016) investigating visuospatial dysfunction in dementia was conducted.
RESULTS: Tests measuring construction, specifically Block Design and Clock Drawing Test, and visual memory, specifically Rey-Osterrieth Complex Figure recall and topographical tasks, show the greatest diagnostic potential in dementia. The Benton visual retention, Doors and People, and topographical memory tests show potential as prognostic markers. DISCUSSION: Tests of visuospatial function demonstrate significant diagnostic and prognostic potential in dementia. Further studies with larger samples of pathologically confirmed cases are required to verify clinical utility.

Entities:  

Keywords:  Alzheimer's disease; Benton visual retention test; Clock Drawing Test; Dementia with Lewy bodies; Diagnosis; Frontotemporal dementia; Prognosis; Rey-Osterrieth Complex Figure; Vascular dementia; Visual object space perception battery; Visuospatial

Year:  2017        PMID: 29780858      PMCID: PMC5956809          DOI: 10.1016/j.dadm.2017.10.004

Source DB:  PubMed          Journal:  Alzheimers Dement (Amst)        ISSN: 2352-8729


Introduction

Overlapping and evolving symptoms make existing clinical diagnostic criteria for dementia [1] difficult to apply in a considerable proportion of patients [2]. In vivo markers of brain pathology (e.g., cerebrospinal fluid or amyloid PET imaging) [3] are still largely confined to research settings, so dementia is still primarily diagnosed on clinical grounds [4]. A final pathological diagnosis is restricted to the very few individuals who undergo postmortem examination or those in whom a genetic cause of dementia is identified. This diagnostic ambiguity is unacceptable because it hampers efforts to develop therapies by restricting clinical trial enrollment or necessitating large clinical trials to demonstrate efficacy [4]. It is challenging to make a diagnosis of AD in the earliest stages or in undifferentiated dementia presentations. Distinct atypical AD syndromes are recognized and characterized by prominent visual symptoms (e.g., posterior cortical atrophy), progressive aphasia (e.g., logopenic progressive aphasia), or motor symptoms (e.g., corticobasal syndrome). A proportion of AD patients will not meet the criteria for any single dementia syndrome, including the recognized atypical AD syndromes, but rather present with an undifferentiated mix of cognitive and behavioral symptoms and signs [2]. In vivo diagnostic markers of amyloid pathology have existed for more than 10 years but have not been deployed clinically due to issues with availability, cost, and specificity. For instance, Pittsburgh compound type B positron emission tomography presents logistical problems because of its cost and short half-life [5]. Cerebrospinal fluid analyses require an invasive procedure and demonstrate only modest specificity in undifferentiated dementia syndromes [6], [7]. Meanwhile, the diagnostic utility of structural neuroimaging in early AD is controversial as atrophy may be subtle or nonspecific [8]. Before the development of amyloid biomarkers, efforts to improve AD diagnosis emphasized improving neuropsychological tests of memory [9], [10]. Memory deficits are characteristic of typical AD, but similar deficits of immediate and delayed episodic memory [11], [12], [13] and autobiographical memory [14], [15] have been reported in frontotemporal dementia (FTD). Separately, early language impairment, which is characteristic of language forms of FTD, can be seen in AD [16], and individuals with nonfluent aphasia due to AD remain difficult to distinguish from patients with the progressive nonfluent aphasia phenotype of FTD [17], despite refinement of diagnostic criteria [18]. Limited specificity of memory and language deficits may not be surprising because their neuroanatomical substrates (i.e., the frontal and temporal lobes) can be affected by several underlying pathologies [19], [20], [21]. Unlike memory and language, visuospatial functioning is heavily reliant on parietal lobe integrity [22], [23]. Changes in medial and lateral parietal lobe function or structure occur early in AD [22], [24], [25], [26]. Consequently, tests of visuospatial abilities may prove to be more accurate in differentiating AD and non-AD dementias than other cognitive tests [8], [27], [28]. This review evaluates studies of visuospatial dysfunction in patients with AD, FTD, and other dementias often associated with AD pathology such as dementia with Lewy bodies (DLB) and vascular dementia (VaD). First, a critical overview of the various components of visuospatial function and their neural bases is presented. Then, the diagnostic and prognostic potential of visuospatial tasks in AD and non-AD dementias is considered.

Methods

Studies of visuospatial dysfunction in dementia were identified using a systematic search process. A combination of keywords, including “visuospatial function,” “Alzheimer's disease,” “frontotemporal dementia,” “dementia with Lewy bodies,” “vascular dementia,” and “neuropsychological test,” was searched in MEDLINE, EMBASE, and PubMed, generating a total of 297 abstracts from 1960 to 2016. Duplicates, non-English articles, and case studies/series were excluded. Articles were excluded primarily because of their focus on neurological disorders, neuropsychological tests, and cognitive domains beyond the scope of this review. Preference was given to studies of pathologically confirmed dementia cohorts. Seventy-two additional records were identified through bibliographic research. These were reviewed for relevance, and 100 papers comprising review articles and experimental studies regarding visuospatial function in dementia remained for full review. If peer-reviewed original studies or review articles were not available, textbooks were consulted.

What is visuospatial function?

Broadly defined, visuospatial function is the ability to specify the parts and overall configuration of a percept, appreciate its position in space, integrate a coherent spatial framework, and perform mental operations on spatial concepts [22], [23]. Visuospatial function is commonly conceptualized in three components: visual perception, construction, and visual memory [29]. At its most basic level, visual perception involves light perception, contrast sensitivity, stimulus orientation, visual acuity, detection of color and motion, and processes mediated primarily by the occipital cortices. Progressive integration of this visual perception involves input from the parietal, temporal, and frontal cortices. Progressive integration of visual information occurs via two major visual processing streams: the ventral “what” stream and the dorsal “where” stream [27], [30], [31]. The ventral stream is responsible for (1) resolving visual interference; (2) the ability to identify an object masked by an overlapping picture; and (3) the ability to make sense of fragmented or ambiguously presented objects [29]. The dorsal “where” stream is responsible for spatial orientation and relies on posterior and inferior parietal regions [29]. Visual memory consists of two main components: recall (or recognition) of visual information and topographical memory. Topographical memory involves perception and encoding of spatial orientation to navigate surroundings. Topographical orientation is characterized as being either egocentric (relative to the self) or allocentric (relative to other objects).

Incidence of visuospatial deficits in dementia

Visuospatial dysfunction is among the earliest manifestations of AD [8], [32], eventually affecting 20%–43% of patients [27], [32], [33], [34]. One study showed disabling visuospatial disorientation in more than one-third of AD patients [35] while almost half of patients complained of visuospatial problems when questioned directly [34]. AD patients may describe impaired discrimination of form, colors and contrast, motion detection, as well as disturbances of higher order functions such as reading, visuospatial orientation, and visual search strategies [8], [27], [31], [32]. Recent work also indicates marked deficits in the ability to mentally envisage and provide accurate descriptions of visuospatial scenes in AD [36]. Deficits in processing of visuospatial information are present in some, but not all, dementias. For example, DLB is characterized by visual hallucinations, visual agnosia, and constructional impairments [37], [38]. Visuospatial deficits, more particularly impaired constructional praxis, results in poor size and form discrimination, misidentification of overlapping figures, and poor visual counting on neuropsychological testing [22], [37]. In this disease, these deficits have been associated with abnormalities of the primary visual and visual association cortices on brain imaging [22], [37], [38], [39]. In contrast, visuospatial abilities appear to be relatively preserved in the early stages of FTD, likely explained by the relative sparing of posterior brain structures by the disease [37], [39], [40], [41].

Neuropsychological tests assessing visuospatial function

A potential diagnostic marker?

A range of neuropsychological tests have been developed to assess visuospatial function, spanning from traditional paper-based tests to interactive computer simulations. Many visuospatial tasks rely on other cognitive abilities (e.g., memory, attention, and executive planning) and motor function, which often complicates interpretation of performance [8], [22], [38]. Several studies (Table 1) have demonstrated diagnostic potential for visuospatial tests in distinguishing AD from non-AD dementia syndromes [8] and in detecting dementias associated with AD copathology [38]. Studies investigating tests of visuospatial function as markers of AD pathology in undifferentiated or uncertain dementia presentations are sparse, and further research is required [8], [25], [39].
Table 1

Summary of studies comparing visuospatial function in AD, DLB, FTD, and VaD

TestStudiesSubtest/scoringResults
Visual perceptionCalderon et al., 2001 [45]Incomplete lettersDLB < AD
 VOSPSilhouettesDLB = AD
Cube analysisDLB < AD
Siri et al., 2001 [44]Cube analysisAD < FTD
Pengas et al., 2010 [73]Cube analysisAD = semantic dementia
 JLOOta et al., 2015 [65]Overall scoreDLB < AD
Simard et al., 2003 [47]Overall scoreDLB = AD
Hodges et al., 1999 [49]Overall scoreAD = FTD
Grossi et al., 2002 [48]Overall scoreAD = FTD
ConstructionShimomura et al., 1998 [63]WAIS-IIIDLB < AD
 Block designHansen et al., 1990 [61]WAIS-IIIDLB < AD
Galasko et al., 1996 [59]WISCDLB < AD
Johnson et al., 2005 [62]WISCDLB/AD < DLB < AD
Rascovsky et al., 2002 [56]WISCAD < FTD
 CDTOta et al., 2015 [65]CopyDLB = AD
Galasko et al., 1996 [59]CopyDLB < AD
Gnanalingham et al., 1997 [60]CopyDLB < AD
Cahn-Weiner et al., 2003 [64]CommandDLB = AD
Blair et al., 2006 [40]CommandAD < FTD
Rascovsky et al., 2002 [56]Copy and commandAD < FTD
Schmidtke and Olbrich, 2007 [54]Circle predrawnAD = FTD
Moretti et al., 2002 [55]Circle predrawnAD < FTD = VaD
Libon et al., 1993 [68]CopyVaD < AD
Kitabayashi et al., 2001 [67]CommandVaD < AD
Heinik et al., 2002 [66]CommandVaD < AD
 RCF copyGrossi et al., 2002 [48]CopyAD = FTD
Kramer et al., 2003 [57]CopyAD = FTD
Irish et al., 2014 [12]CopyAD = FTD
Pachana et al., 1996 [41]CopyAD < FTD
Irish et al., 2016 [88]CopyAD < semantic dementia
Pengas et al., 2010 [73]CopyAD < semantic dementia
Visual memoryKramer et al., 2003 [57]RecallAD < FTD
 RCF recallPerry and Hodges, 2000 [89]RecallAD < FTD
Siri et al., 2001 [44]RecallAD < FTD
Pachana et al., 1996 [41]RecallAD < FTD
Irish et al., 2014 [12]RecallAD = FTD
Galton et al., 2001 [90]RecallAD < semantic dementia
Pengas et al., 2010 [73]RecallAD < semantic dementia
Irish et al., 2016 [88]RecallAD < semantic dementia
 Benton visual retention testGrossi et al., 2002 [48]CopyAD = FTD
Johnson et al., 2005 [62]Copy and recallDLB/AD < DLB < AD
 DoorsIrish et al., 2014 [12]RecognitionAD = bvFTD
Graham et al., 2004 [71]RecognitionAD = VaD
 Virtual supermarket testTu et al., 2015 [72]AD < FTD
 Virtual route learning taskPengas et al., 2010 [73]AD < semantic dementia
 CANTAB PALLee et al., 2003 [77]AD < FTD
 CANTAB MTSLee et al., 2003 [77]AD = FTD

Abbreviations: AD, Alzheimer's disease; DLB, dementia with Lewy bodies; FTD, frontotemporal dementia; VaD, vascular dementia; VOSP, visual object and space perception battery; JLO, judgment of line orientation; CDT, Clock Drawing Test; RCF, Rey-Osterrieth Complex Figure; CANTAB, Cambridge Neuropsychological Test Automated Battery; PAL, Paired Associates Learning Task; MTS, matching-to-sample task.

Summary of studies comparing visuospatial function in AD, DLB, FTD, and VaD Abbreviations: AD, Alzheimer's disease; DLB, dementia with Lewy bodies; FTD, frontotemporal dementia; VaD, vascular dementia; VOSP, visual object and space perception battery; JLO, judgment of line orientation; CDT, Clock Drawing Test; RCF, Rey-Osterrieth Complex Figure; CANTAB, Cambridge Neuropsychological Test Automated Battery; PAL, Paired Associates Learning Task; MTS, matching-to-sample task.

Visual perception

Higher visual processing is commonly assessed using the visual object and space perception battery (VOSP) [42]. For example, the “incomplete letters” subtest is an efficient test of visual interference [27], [43] while spatial skills are assessed via the “cube analysis” and “dot counting” subtests. The VOSP is simple, paper-based, and independent of language and motor function [27], [29], [43]. Administration of the full suite of tasks, however, is time consuming and performance requires intact attention which is often compromised in AD [29], [43]. Although evidence is limited, the “cube analysis” subtest may be helpful in discriminating AD from FTD [44]. Meanwhile, DLB patients appear to be impaired on the VOSP, with some studies reporting equivalent or worse performance than in AD patients depending on the subtest [45]. Spatial orientation may also be assessed by Benton's judgment of line orientation (JLO) test [46]. The JLO test requires minimal motor skills and comprehension abilities, is free of practice effects, and addresses a relatively low-level visuospatial skill [43]. Disadvantages include administration time (30 items), dependence on intact visual attention [29], and an oversimplified multiple-choice format [47]. Like the VOSP, the total score of the JLO test may show little difference between dementia syndromes [47], [48], [49], but detailed error analysis might be more useful [47].

Construction

Object movement tasks, such as the Block Design subtest from the Wechsler adult intelligence scales IV [50] and 3D block construction [51], are often used to assess constructional ability [27]. Both tests involve secondary functions including spatial orientation, motor skills, and executive planning, so separating the contributions of each function is difficult [27], [29]. Drawing tasks such as the Clock Drawing Test (CDT) and the Rey-Osterrieth Complex Figure (RCF) [52] test are commonly used to assess construction [27]. The CDT copy (where the picture of a clock is shown) and command (where the clock is drawn from memory) components are quick and easy to administer, irrespective of culture and language (Fig. 1) [27], [43], [53]. The test requires executive processing, semantic and linguistic competence, numerical knowledge, motor skills, memory concentration, and attention [40], [53]. Although this complex integration of functions makes the CDT an excellent screening tool [22], [40], [53], its ability to differentiate focal impairments without error analysis is modest [40], [53]. For this reason, over a dozen scoring criteria have been proposed to categorize errors; however, none have achieved universal acceptance [40].
Fig. 1

Clock Drawing Test (A–D). Four examples of increasingly impaired clock faces from different patients with dementia.

Clock Drawing Test (A–D). Four examples of increasingly impaired clock faces from different patients with dementia. The RCF test (Fig. 2) requires executive planning, organization, motor, spatial orientation, attention, and concentration, all of which contribute to intact performance [22], [27], [29], [43]. Some aspects of the RCF test scoring system are subject to ambiguity (e.g., the distinction of distortion compared to misplacement). Furthermore, the scoring system neglects qualitative aspects of performance such as strategy, delays, and organization [43].
Fig. 2

Rey-Osterrieth Complex Figure (A–D). Four examples of increasingly impaired copy drawings of the original Rey-Osterrieth Complex Figure across different dementia subtypes.

Rey-Osterrieth Complex Figure (A–D). Four examples of increasingly impaired copy drawings of the original Rey-Osterrieth Complex Figure across different dementia subtypes. Variability in test paradigms and the impact of other cognitive or motor impairments [43], [54] limit the reliability of construction tasks as markers of AD. For example, FTD patients perform better than AD patients on the block design and CDT [40], [55], [56], but performance on the RCF copy is less consistent [12], [41], [48], [57], perhaps reflecting executive planning impairment and impulsivity in FTD [8], [58], rather than visuospatial deficits per se. The pattern in DLB is unclear; some studies demonstrate worse performance on construction tasks than in AD [59], [60], [61], [62], [63], while others report the opposite pattern [64], [65]. Inattention, impaired motor skills, and executive dysfunction in DLB have all been proposed as potential confounds on construction tasks [64], [65]. VaD patients have been shown to perform worse on the CDT than AD patients [66], [67], [68]. In a study by Moretti, these findings were contradicted [55]; however, their predrawn circle may measure numerical and spatial ability rather than construction.

Visual memory

The delayed recall component of the RCF (i.e., reproduction from memory after a delay of 3–45 minutes) is a common test used to assess visual recall and recognition. This test, however, is subject to the same confounds as the copy component [43]. Visual recognition memory can be tested using tasks such as the Benton visual retention test [69], which incorporates visual recognition, recall, and spatial orientation [69], as well as additional motor, construction, and visual perception abilities [29]. Impulsivity, however, may impair performance, and correct responses may be determined strategically [43]. Nevertheless, the Benton visual retention test has been rarely administered across dementia syndromes, and thus, its diagnostic utility in this context remains unclear. The doors subtest of the “Doors and People” test is a forced visual recognition multiple-choice test involving pictures of doors. The test primarily detects a learning deficit, particularly in the early stages of AD [70]. Again, this test has not been extensively tested across the range of dementia syndromes; however, the available evidence demonstrates little value in discriminating AD from FTD or VaD [12], [71].

New directions in the assessment of visuospatial dysfunction

Computerized testing paradigms to assess topographical memory demonstrate promise as diagnostic tools for AD. Topographical memory tests represent a novel and ecologically valid approach to test functions purported to rely on the integrity of posterior parietal brain regions. Computerized tests of topographical memory are increasingly being used to simulate virtual environments and engage egocentric spatial processes, while reducing motor and language demands. For example, the virtual supermarket [72] and the virtual route learning tests [73] guide the participant through a supermarket and town, respectively, and require the participant to repeat routes, choose a route to a specific landmark, or indicate the direction of the starting point [72], [73]. Early studies have demonstrated that patients with FTD tend to outperform those with AD on such computerized topographical memory tasks, even after accounting for episodic memory differences [72]. A systematic review confirms the clinical utility of topographical memory tasks in distinguishing AD from FTD [74]. The use of computerized testing protocols and automated scoring may reduce administration and interpretation time, making these approaches particularly appealing for use in dementia. Computerized tests of visuospatial memory also show promise as AD diagnostic tools. For example, performance on the Groton Maze Learning Test [75], which incorporates testing of visuospatial memory and executive function, appears sensitive to cognitive changes in healthy aging. The Cambridge Neuropsychological Test Automated Battery is a battery of computerized tests, including the Paired Associates Learning (PAL) task and the simultaneous and delayed matching-to-sample (MTS) tasks [76]. The PAL task primarily tests visuospatial associative learning. In this task, a visual stimulus is briefly displayed in one of up to eight boxes. The stimulus later reappears, and the subject must choose which box it was originally displayed in. The MTS task is a purer task of visual recognition memory, where a rectangular pattern is shown and must be matched to 1 of 4 options displayed below; the options are presented simultaneously to the original stimulus or after a delay [77]. One small study demonstrated significantly poorer performance on the PAL task in AD than in FTD. Although performance on the MTS task did not differ between groups overall, the pattern of errors differed slightly between diagnostic groups [77]. Similar studies have demonstrated impaired performance in AD compared to controls [77], [78], [79], [80], and relatively intact performance in FTD compared to controls [81], on both PAL and MTS tasks. A further study reported even greater impairment in DLB than in AD patients on the delayed MTS task [82]. The CogState battery includes tests of visual recognition (One Card Learning), visual recall (Continuous Paired Associate Learning), and visual attention (Identification task) [83], [84]. A number of small studies comparing performance on these tasks demonstrated little discriminative ability between AD, DLB, and FTD [85], [86], [87]. Studies of computerized testing protocols in larger patient cohorts are required to establish their clinical utility.

Prognostic marker

Visuospatial function shows potential as a cognitive marker for the detection of preclinical AD [10], [27]. Specifically, visuospatial deficits may be detected up to 5 years before the onset of AD symptoms in a nondemented elderly population [91] often before the development of frank memory impairment [25], [92]. Separately, one study of 1425 participants demonstrated that six errors or more on the Benton visual retention test doubled the risk of developing AD, even up to 15 years before diagnosis [93]. The Doors and People test has demonstrated value in predicting those who convert from mild cognitive impairment (MCI) to AD [94], [95], as have tests of topographical memory [10], [27], [93], [96], the Groton Maze Learning Test [97], and the PAL task of the Cambridge Neuropsychological Test Automated Battery [78], [94], [98]. The rates of decline in performance on computerized visual memory tasks have also been associated with amyloid deposition on PiB-PET in healthy controls and patients with MCI or conversion from MCI to AD. Specifically, declines in performance on the Cogstate's One Card Learning, One Back Learning, and Continuous Paired Associate tasks over 36 months were reported to be significantly greater in controls and MCI patients with high amyloid deposition than those with low amyloid deposition [99]. Furthermore, intraindividual decline in the One Card Learning task was predictive of cerebral amyloid deposition in healthy elderly adults [100].

Summary

The diagnosis and management of dementia is challenging, in part because of diagnostic uncertainty and variability in prognosis. Visuospatial function is a relatively underreported symptom that relies on parietal lobes structures that are damaged in early-stage AD. Neuropsychological measures of visuospatial function may offer a practical and noninvasive approach to the diagnosis of AD or AD copathology. Current neuropsychological assessments demonstrate significant diagnostic and prognostic potential, but existing studies are limited by small numbers, clinically defined (not autopsy-confirmed) cohorts [38], and confounds by nonvisuospatial cognitive abilities and/or motor deficits. Tests of topographical memory demonstrate the greatest promise, but further studies with larger sample sizes of pathologically confirmed cases are required, as a prelude to implementation in diagnostically undifferentiated dementia cohorts. Systematic review: A systematic search of studies (1960–2016) investigating visuospatial dysfunction in dementia was conducted. The resulting articles were evaluated, and 100 papers remained for full review. Interpretation: Our study has demonstrated that neuropsychological measures of visuospatial function may prove sensitive to parietal lobe damage, offering a practical and noninvasive approach to the diagnosis of AD or AD copathology. Tests of construction, specifically Block Design and Clock Drawing Test, and visual memory, specifically Rey Complex Figure recall and topographical tasks, show the greatest diagnostic potential. The Benton visual retention, Doors and People, and topographical memory tests show potential as prognostic markers. Future direction: Existing studies are limited by small numbers, non–autopsy-confirmed cohorts, and are potentially confounded by nonvisuospatial cognitive abilities and/or motor deficits. Further studies with larger sample sizes of pathologically confirmed cases are required.
  86 in total

1.  Three-dimensional constructional praxis. A clinical test.

Authors:  A L BENTON; M L FOGEL
Journal:  Arch Neurol       Date:  1962-10

2.  Cognitive loss in dementia with Lewy bodies and Alzheimer disease.

Authors:  T Shimomura; E Mori; H Yamashita; T Imamura; N Hirono; M Hashimoto; S Tanimukai; H Kazui; T Hanihara
Journal:  Arch Neurol       Date:  1998-12

3.  Independent comparison of CogState computerized testing and a standard cognitive battery with neuroimaging.

Authors:  Michelle M Mielke; Stephen D Weigand; Heather J Wiste; Prashanthi Vemuri; Mary M Machulda; Davis S Knopman; Val Lowe; Rosebud O Roberts; Kejal Kantarci; Walter A Rocca; Clifford R Jack; Ronald C Petersen
Journal:  Alzheimers Dement       Date:  2014-11-15       Impact factor: 21.566

4.  Visual memory predicts Alzheimer's disease more than a decade before diagnosis.

Authors:  C H Kawas; M M Corrada; R Brookmeyer; A Morrison; S M Resnick; A B Zonderman; D Arenberg
Journal:  Neurology       Date:  2003-04-08       Impact factor: 9.910

5.  Verbal and visuospatial deficits in dementia with Lewy bodies.

Authors:  David K Johnson; John C Morris; James E Galvin
Journal:  Neurology       Date:  2005-10-25       Impact factor: 9.910

6.  Clinical and neuropathological findings in Lewy body dementias.

Authors:  D Galasko; R Katzman; D P Salmon; L Hansen
Journal:  Brain Cogn       Date:  1996-07       Impact factor: 2.310

7.  Specific impairments in visuospatial working and short-term memory following low-dose scopolamine challenge in healthy older adults.

Authors:  Elizabeth Thomas; Peter J Snyder; Robert H Pietrzak; Colleen E Jackson; Martin Bednar; Paul Maruff
Journal:  Neuropsychologia       Date:  2008-04-22       Impact factor: 3.139

8.  Distinct neuroanatomical substrates and cognitive mechanisms of figure copy performance in Alzheimer's disease and behavioral variant frontotemporal dementia.

Authors:  Katherine L Possin; Victor R Laluz; Oscar Z Alcantar; Bruce L Miller; Joel H Kramer
Journal:  Neuropsychologia       Date:  2010-10-26       Impact factor: 3.139

9.  Visual dysfunction in Alzheimer's disease: relation to normal aging.

Authors:  A Cronin-Golomb; S Corkin; J F Rizzo; J Cohen; J H Growdon; K S Banks
Journal:  Ann Neurol       Date:  1991-01       Impact factor: 10.422

10.  Dementia trials and dementia tribulations: methodological and analytical challenges in dementia research.

Authors:  Craig W Ritchie; Graciela Muniz Terrera; Terence J Quinn
Journal:  Alzheimers Res Ther       Date:  2015-03-18       Impact factor: 6.982

View more
  20 in total

1.  Exploring Information Flow from Posteromedial Cortex during Visuospatial Working Memory: A Magnetoencephalography Study.

Authors:  Erin Goddard; Erika W Contini; Muireann Irish
Journal:  J Neurosci       Date:  2022-06-22       Impact factor: 6.709

2.  Development of the Colorado posterior cortical questionnaire within an Alzheimer's disease study cohort.

Authors:  Samantha K Holden; Victoria S Pelak; Trevor Sooy; Kate S Heffernan; Brice V McConnell; Peter S Pressman; Brianne M Bettcher
Journal:  J Clin Exp Neuropsychol       Date:  2022-08-01       Impact factor: 2.283

Review 3.  Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia? Review of Key Points Toward an Accurate Clinical and Neuropsychological Diagnosis.

Authors:  Gada Musa; Andrea Slachevsky; Carlos Muñoz-Neira; Carolina Méndez-Orellana; Roque Villagra; Christian González-Billault; Agustín Ibáñez; Michael Hornberger; Patricia Lillo
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

4.  To Explore the Predictive Power of Visuomotor Network Dysfunctions in Mild Cognitive Impairment and Alzheimer's Disease.

Authors:  Justine Staal; Francesco Mattace-Raso; Hennie A M Daniels; Johannes van der Steen; Johan J M Pel
Journal:  Front Neurosci       Date:  2021-06-28       Impact factor: 4.677

5.  Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and 18F-FDG-PET imaging.

Authors:  Julie Ottoy; Ellis Niemantsverdriet; Jeroen Verhaeghe; Ellen De Roeck; Hanne Struyfs; Charisse Somers; Leonie Wyffels; Sarah Ceyssens; Sara Van Mossevelde; Tobi Van den Bossche; Christine Van Broeckhoven; Annemie Ribbens; Maria Bjerke; Sigrid Stroobants; Sebastiaan Engelborghs; Steven Staelens
Journal:  Neuroimage Clin       Date:  2019-03-13       Impact factor: 4.881

6.  Usefulness of the Clock Drawing Test as a Cognitive Screening Instrument for Mild Cognitive Impairment and Mild Dementia: an Evaluation Using Three Scoring Systems.

Authors:  Sangsoon Kim; Seungmin Jahng; Kyung-Ho Yu; Byung-Chul Lee; Yeonwook Kang
Journal:  Dement Neurocogn Disord       Date:  2018-12-09

7.  Stereoscopic Depth Perception and Visuospatial Dysfunction in Alzheimer's Disease.

Authors:  Nam-Gyoon Kim; Ho-Won Lee
Journal:  Healthcare (Basel)       Date:  2021-02-03

8.  Association Between Visual Memory and In Vivo Amyloid and Tau Pathology in Preclinical Autosomal Dominant Alzheimer's Disease.

Authors:  Yamile Bocanegra; Joshua T Fox-Fuller; Ana Baena; Edmarie Guzmán-Vélez; Clara Vila-Castelar; Jairo Martínez; Heirangi Torrico-Teave; Francisco Lopera; Yakeel T Quiroz
Journal:  J Int Neuropsychol Soc       Date:  2020-08-07       Impact factor: 2.892

9.  Neuropsychological profile in the preclinical stages of dementia: principal component analysis approach.

Authors:  Claudia Rivera-Fernández; Nilton Custodio; Marcio Soto-Añari
Journal:  Dement Neuropsychol       Date:  2021 Apr-Jun

10.  Evaluating cognitive profiles of patients undergoing clinical amyloid-PET imaging.

Authors:  Flavia Loreto; Stephen Gunning; Mara Golemme; Hilary Watt; Neva Patel; Zarni Win; Christopher Carswell; Richard J Perry; Paresh A Malhotra
Journal:  Brain Commun       Date:  2021-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.